Heather DiBenedetto is the Head of Therapeutic Operations at Moderna Therapeutics and is based in Cambridge, MA. Moderna Therapeutics is a platform company focused on messenger RNA therapies across a broad range of therapeutic areas including immune-oncology, infectious disease, rare disease and cardiovascular. Heather joined Moderna Therapeutics in 2016 from Novartis, Translational Clinical Oncology where she was the Global Head of Clinical Operations. She managed a global team of ~120 clinical operations, clinical scientists, compliance, planning, operational excellence and biomarker professionals overseeing >60 global oncology studies. Prior to Novartis, Heather led a Strategic Partnership and Start up group at Millennium Pharmaceuticals (now Takeda. Previously Heather held roles of increasing responsibilities on both the Biotech and CRO side. Heather holds a M.S. degree in Drug Regulatory Affairs & Health Policy from the Massachusetts College of Pharmacy & Health Sciences and a B.A. in Zoology from the University of Vermont. Heather is Regulatory Affairs (US) certified.